StreetAlpha
Biogen Inc. · SEC Form 4

BIIB Insider Trading

From SEC Form 410 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Biogen Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $585 bought and $905K sold.

← BIIB stock page

Insiders are net sellers
Bought, 12 months$5851 buys · 1 insiders
Sold, 12 months$905K3 sales · 2 insiders
Net−$905Kbought minus sold
Planned sales100%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJan2026-02: bought $5852026-02: sold $666KFebMarAprMayJunJul2026-08: sold $240KAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when BIIB insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an BIIB officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every BIIB insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Aug 4, 2026Lloyd MinorDirectorSale plan1,186$202.15$240K2,689Aug 5Form 4
Feb 12, 2026Nicole MurphyHead of Pharm Ops and TechBuy3$195.04$58519,611Feb 17Form 4
Feb 9, 2026Priya SinghalHead of DevelopmentSale plan2,660$199.83$532K8,043Feb 10Form 4
Feb 2, 2026Priya SinghalHead of DevelopmentSale plan748$179.30$134K6,271Feb 3Form 4
Sep 2, 2025Priya SinghalHead of DevelopmentSale plan517$133.55$69K5,772Sep 2Form 4
Jul 8, 2025Rachid IzzarHead of Global Product Strat.Sale plan2,223$135.00$300K6,330Jul 16Form 4
May 19, 2025Priya SinghalHead of DevelopmentSale plan3,806$126.25$481K5,427May 20Form 4
May 2, 2025Caroline DorsaDirectorBuy1,235$122.72$152K27,842May 5Form 4
Mar 7, 2025Stephen A SherwinDirectorSale plan8,760$150.02$1.3M11,318Mar 10Form 4
Dec 9, 2024Priya SinghalHead of DevelopmentSale plan110$157.21$17K5,426Dec 9Form 4

BIIB insider trading FAQ

Are BIIB insiders buying or selling?

Insiders are net sellers over the last 12 months. 1 insiders bought $585 of BIIB on the open market in 1 trades, and 2 sold $905K in 3 trades, 100% of that under pre-arranged trading plans.

When did an BIIB insider last buy shares?

Nicole Murphy (Head of Pharm Ops and Tech) bought 3 shares for $585 on Feb 12, 2026, reported on Feb 17, 2026.

When did an BIIB insider last sell shares?

Lloyd Minor (Director) sold 1,186 shares for $240K on Aug 4, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice